NX1ASXNexalis Therapeutics Ltd

NX1 price activity

Last Price

Change (24hr)

AUD (%)

Volume

Volume (4w avg)

Previous Close

N/A

Last Trade

NX1 price performance

10%

-62.07%

YTD

-62.07%

NX1 price fundamentals

N/A

Shares Issued

N/A

Earnings Per Share (EPS)

N/A

Dividends Per Share (DPS)

N/A

P/E Ratio

Price market cap

Market cap

N/A

AU-ASX rank

N/A

Sector Rank

N/A

NX1 details

View company website

View AU-ASX Official Page

NX1 Market Signals

More ways to discover

Browse Australia news Discover ASX signals Browse all ASX stocks

Nexalis Therapeutics Ltd (AU-ASX: NX1)

Nexalis Therapeutics Limited, a biotechnology company, develops and sells registrable inhaled drug-device combinations in Australia. The company develops IRX-211 for the management of breakthrough cancer pain and IRX-616a for the treatment of panic disorder, which are inhaled medications delivered through a pressurized metered dose inhaler. It also develops SRX-25 for treatment resistant depression. The company was formerly known as InhaleRx Limited and changed its name to Nexalis Therapeutics Limited in January 2026. Nexalis Therapeutics Limited was incorporated in 2016 and is based in Melbourne, Australia.

Price: A$0.01

Sector: Healthcare — Biotechnology